The DOI matches its Crossref record.
Protein kinase inhibitor peptide (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“especially in the brain, where both PKI isoforms and PKA are highly expressed (Figure 7) 73, 74.”
From Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A (2023) · cites this paper as [73]
In the citing paper
“PKI isoforms are also highly expressed in the brain, especially PKIα”
From Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A (2023) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 81
- Ashby, 1972, Characterization of the interaction of a protein inhibitor with adenosine 3′,5′-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase, J. Biol. Chem., 247, 6637, 10.1016/S0021-9258(19)44739-X · DOI · Paper page
- Ashby, 1973, Characterization of the interaction of a protein inhibitor with adenosine 3′,5′-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme, J. Biol. Chem., 248, 1255, 10.1016/S0021-9258(19)44290-7 · DOI · Paper page
- Baude, 1994, Glutamic acid 203 of the cAMP-dependent protein kinase catalytic subunit participates in the inhibition by two isoforms of the protein kinase inhibitor, J. Biol. Chem., 269, 2316, 10.1016/S0021-9258(17)42170-3 · doi:10.1016/s0021-9258(17)42170-3
- Beale, 1977, Isolation and characterization of a protein from rat testis which inhibits cyclic AMP-dependent protein kinase and phosphodiesterase, J. Biol. Chem., 252, 6322, 10.1016/S0021-9258(17)39959-3 · doi:10.1016/s0021-9258(17)39959-3
- Beebe, 1986, Cyclic nucleotide-dependent protein kinases, The Enzymes, 17, 43, 10.1016/S1874-6047(08)60428-X · DOI
- Brindle, 1992, The CREB family of transcription activators, Curr. Opinion Genet. Develop., 2, 199, 10.1016/S0959-437X(05)80274-6 · DOI · Paper page
- Cassoni, 1997, Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A, Int. J. Cancer, 72, 340, 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I · DOI
- Chen, 2005, Endogenous protein kinase inhibitor γ terminates immediate-early gene expression induced by cAMP-dependent protein kinase (PKA) signaling, J. Biol. Chem., 280, 2700, 10.1074/jbc.M412558200 · DOI
- Cheng, 1986, A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase, J. Biol. Chem., 261, 989, 10.1016/S0021-9258(17)36041-6 · DOI · Paper page
- Colledge, 1999, Akaps: from structure to function, Trends Cell Biol., 9, 216, 10.1016/S0962-8924(99)01558-5 · DOI · Paper page
- Collins, 1997, Characterization of PKIγ, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase, J. Biol. Chem., 272, 18169, 10.1074/jbc.272.29.18169 · DOI · Paper page
- Corbin, 1988, Mechanism and function of cAMP- and cGMP-dependent protein kinases, Adv. Second Messenger Phosphoprotein Res., 21, 75
- Dalton, 2005, Alterations in brain protein kinase A activity and reversal of morphine tolerance by two fragments of native protein kinase A inhibitor peptide (PKI), Neuropharmacology, 48, 648, 10.1016/j.neuropharm.2004.12.006 · DOI
- De Lecea, 1998, Endogenous protein kinase a inhibitor (PKIα) modulates synaptic activity, J. Neurosci. Res., 53, 269, 10.1002/(SICI)1097-4547(19980801)53:3<269::AID-JNR1>3.0.CO;2-8 · DOI · Paper page
- Demaille, 1977, Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3′,5′-monophospate dependent protein kinases, Biochemistry, 16, 3080, 10.1021/bi00633a006 · DOI
- Dudai, 1987, The cAMP cascade in the nervous system: molecular sites of action and possible relevance to neuronal plasticity, Crit. Rev. Biochem., 22, 221, 10.3109/10409238709101484 · DOI
- Duffy, 2003, Postsynaptic application of a peptide inhibitor of cAMP-dependent protein kinase blocks expression of long-lasting synaptic potentiation in hippocampal neurons, J. Neurosci., 23, 1142, 10.1523/JNEUROSCI.23-04-01142.2003 · DOI
- Fantozzi, 1994, Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus, J. Biol. Chem., 269, 2676, 10.1016/S0021-9258(17)41997-1 · DOI
- Farrow, 2003, Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A, Surgery, 134, 197, 10.1067/msy.2003.220 · DOI
- Feliciello, 1999, Yotiao protein, a ligand for the NMDA receptor, binds and targets cAMP-dependent protein kinase II, FEBS Lett., 464, 174, 10.1016/S0014-5793(99)01585-9 · DOI
- Gamm, 1995, Isoform-specific differences in the potencies of murine protein kinase inhibitors are due to non-conserved amino-terminal residues, J. Biol. Chem., 270, 7227, 10.1074/jbc.270.13.7227 · doi:10.1074/jbc.270.13.7227
- Gangolli, 2000, Deficient gene expression in protein kinase inhibitor α null mutant mice, Mol. Cellular Biol., 20, 3442, 10.1128/MCB.20.10.3442-3448.2000 · DOI · Paper page
- Gill, 1976, Purification and characterization of 3′:5′-cyclic GMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 73, 3918, 10.1073/pnas.73.11.3918 · DOI
- Glass, 1986, Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein, J. Biol. Chem., 261, 12166, 10.1016/S0021-9258(18)67218-7 · doi:10.1016/s0021-9258(18)67218-7
- Glass, 1989, Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein, J. Biol. Chem., 264, 8802, 10.1016/S0021-9258(18)81864-6 · DOI · Paper page
- Glass, 1989, Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10, J. Biol. Chem., 264, 14579, 10.1016/S0021-9258(18)71718-3 · DOI · Paper page
- Glass, 1992, Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides, Biochemistry, 31, 1728, 10.1021/bi00121a021 · doi:10.1021/bi00121a021
- Gonzalez, C.G., 1962. Activation characteristics of phosphorylase kinase. M.S. thesis, University of Washington.
- Gonzalez, 1989, Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133, Cell, 59, 675, 10.1016/0092-8674(89)90013-5 · DOI · Paper page
- Habener, 1990, Cyclic AMP response element binding proteins: a cornucopia of transcription factors, Mol. Endocrinol., 4, 1087, 10.1210/mend-4-8-1087 · DOI · Paper page
- Harootunian, 1993, Movement of the free catalytic subunit of cAMP-dependent protein kinase into and out of the nucleus can be explained by diffusion, Mol. Biol. Cell, 4, 993, 10.1091/mbc.4.10.993 · DOI · Paper page
- Hauer, 1999, Two well-defined motifs in the cAMP-dependent protein kinase inhibitor (PKIα) correlate with inhibitory and nuclear function, Protein Sci., 8, 545, 10.1110/ps.8.3.545 · doi:10.1110/ps.8.3.545
- Henderson, 2000, A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals, Exp. Cell Res., 256, 213, 10.1006/excr.2000.4825 · DOI · Paper page
- Hofmann, 1980, Apparent constants for the interaction of regulatory and catalytic subunit of cAMP-dependent protein kinases I and II, J. Biol. Chem., 255, 1559, 10.1016/S0021-9258(19)86069-6 · doi:10.1016/s0021-9258(19)86069-6
- Jicha, 1999, cAMP-dependent protein kinase phosphorylations on τ in Alzheimer’s disease, J. Neurosci., 19, 7486, 10.1523/JNEUROSCI.19-17-07486.1999 · DOI · Paper page
- Jin, 2004, Purification and structural study of the β form of human cAMP-dependent protein kinase inhibitor, Eur. J. Biochem., 271, 1768, 10.1111/j.1432-1033.2004.04087.x · doi:10.1111/j.1432-1033.2004.04087.x
- Kawakami, 2001, The role of endogenous PKA inhibitor, PKIα, in organizing left-right axis formation, Development, 128, 2509, 10.1242/dev.128.13.2509 · DOI
- Kelley, 1997, Enhanced reward-related responding following cholera toxin infusion into nucleus accumbens, Synapse, 26, 46, 10.1002/(SICI)1098-2396(199705)26:1<46::AID-SYN5>3.0.CO;2-E · DOI
- Kemp, 1977, Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase, J. Biol. Chem., 252, 4888, 10.1016/S0021-9258(17)40137-2 · DOI · Paper page
- Kind, 2001, Plasticity: downstream of glutamate, Trends Neurosci., 24, 553, 10.1016/S0166-2236(00)01921-4 · DOI
- Knighton, 1991, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 414, 10.1126/science.1862343 · DOI · Paper page
- Krebs, 1956, The phosphorylase b to a converting enzyme of rabbit skeletal muscle, Biochmica et biophysica acta, 20, 150, 10.1016/0006-3002(56)90273-6 · DOI · Paper page
- Krebs, 1958, The muscle phosphorylase b kinase reaction, J. Biol. Chem., 231, 73, 10.1016/S0021-9258(19)77286-X · DOI · Paper page
- Krebs, 1959, Factors affecting the activity of muscle phosphorylase b kinase, J. Biol. Chem., 234, 2867, 10.1016/S0021-9258(18)69685-1 · DOI
- Krebs, 1966, Activation of skeletal muscle phosphorylase, Pharmacol. Rev., 18, 163
- Kumar, 1997, Multiplicity of the β form of the cAMP-dependent protein kinase inhibitor protein generated by post-translational modification and alternate translation initiation, J. Biol. Chem., 272, 20011, 10.1074/jbc.272.32.20011 · doi:10.1074/jbc.272.32.20011
- Kumar, 2002, A dual-specificity isoform of the protein kinase inhibitor PKI produced by alternate gene splicing, Biochem. J., 362, 533, 10.1042/0264-6021:3620533 · DOI
- Lee, 1990, Cyclic AMP responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains, Eur. Mol. Biol. Organization (EMBO) J., 9, 4455, 10.1002/j.1460-2075.1990.tb07896.x · DOI · Paper page
- Lin, 1998, Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1, J. Neurosci., 18, 2017, 10.1523/JNEUROSCI.18-06-02017.1998 · DOI · Paper page
- McPherson, 1979, Possibility of shape conformers of the protein inhibitor of the cyclic adenosine monophosphate dependent protein kinase, Biochemistry, 18, 4835, 10.1021/bi00589a011 · DOI
- Michel, 2002, Akap mediated signal transduction, Ann. Rev. Pharmacol. Toxicol., 42, 235, 10.1146/annurev.pharmtox.42.083101.135801 · DOI · Paper page
- Nestler, 1997, Molecular mechanisms of opiate and cocaine addiction, Curr. Opin. Neurobiol., 7, 713, 10.1016/S0959-4388(97)80094-3 · DOI
- Olsen, 1991, Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase, J. Biol. Chem., 266, 11158, 10.1016/S0021-9258(18)99142-8 · doi:10.1016/s0021-9258(18)99142-8
- Olsen, 1991, Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor, Mol. Endocrinol., 5, 1246, 10.1210/mend-5-9-1246 · DOI
- Posner, 1964, The assay of adenosine-3′,5′-phosphate in skeletal muscle, Biochemistry, 3, 1040, 10.1021/bi00896a005 · DOI
- Posner, 1965, Effects of electrical stimulation and epinephrine on muscle phosphorylase, phosphorylase b kinase, and adenosine 3′,5′-phosphate, J. Biol. Chem., 240, 982, 10.1016/S0021-9258(18)97523-X · DOI · Paper page
- Scarpetta, 1993, Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse, J. Biol. Chem., 268, 10927, 10.1016/S0021-9258(18)82074-9 · DOI
- Scott, 1985, Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci., USA, 82, 4379, 10.1073/pnas.82.13.4379 · DOI · Paper page
- Scott, 1985, Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle, Proc. Natl. Acad. Sci., USA, 82, 5732, 10.1073/pnas.82.17.5732 · DOI · Paper page
- Scott, 1986, Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci., USA, 83, 1613, 10.1073/pnas.83.6.1613 · DOI · Paper page
- Seasholtz, 1995, Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain, Proc. Natl. Acad. Sci., USA, 92, 1734, 10.1073/pnas.92.5.1734 · DOI
- Sun, 2005, Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of τ and spatial memory deficit in rat, FEBS Lett., 579, 251, 10.1016/j.febslet.2004.11.083 · DOI
- Sutherland, 1958, Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles, J. Biol. Chem., 232, 1077, 10.1016/S0021-9258(19)77423-7 · DOI · Paper page
- Taylor, 1990, cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes, Ann. Rev. Biochem., 59, 971, 10.1146/annurev.bi.59.070190.004543 · DOI · Paper page
- Thams, 2005, Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ ATP channel-dependent pathway, Eur. J. Endocrinol., 152, 671, 10.1530/eje.1.01885 · DOI
- Thomas, 1991, Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase, J. Biol. Chem., 266, 10906, 10.1016/S0021-9258(18)99105-2 · doi:10.1016/s0021-9258(18)99105-2
- Tokuda, 1998, Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation, Mol. Neurobiol., 17, 137, 10.1007/BF02802028 · DOI
- Van Patten, 1991, Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase, Proc. Natl. Acad. Sci., USA, 88, 5383, 10.1073/pnas.88.12.5383 · DOI
- Van Patten, 1992, The α- and β-isoforms of the inhibitor protein of the 3′,5′-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression, Mol. Endocrinol., 6, 2114, 10.1210/me.6.12.2114 · doi:10.1210/me.6.12.2114
- Van Patten, 1997, Specific testicular localization and hormonal regulation of the PKIα and PKIβ isoforms of the inhibitor of the cAMP-dependent protein kinase, J. Biol. Chem., 272, 20021, 10.1074/jbc.272.32.20021 · doi:10.1074/jbc.272.32.20021
- Walsh, 1968, An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle, J. Biol. Chem., 243, 3763, 10.1016/S0021-9258(19)34204-8 · DOI · Paper page
- Walsh, 1971, Catalysis of the phosphorylase kinase activation reaction, J. Biol. Chem., 246, 1968, 10.1016/S0021-9258(19)77176-2 · doi:10.1016/s0021-9258(19)77176-2
- Walsh, 1971, Purification and characterization of a protein inhibitor of adenosine 3′,5′-monophosphate-dependent protein kinases, J. Biol. Chem., 246, 1977, 10.1016/S0021-9258(19)77177-4 · DOI · Paper page
- Wen, 1994, Heat-stable inhibitors of cAMP-dependent protein kinase carry a nuclear export signal, J. Biol. Chem., 269, 32214, 10.1016/S0021-9258(18)31623-5 · DOI
- Wen, 1995, Identification of a signal for rapid export of protein from the nucleus, Cell, 82, 463, 10.1016/0092-8674(95)90435-2 · DOI · Paper page
- Wen, 1995, The expression and intracellular distribution of the heat-stable protein kinase inhibitor is cell-cycle regulated, J. Biol. Chem., 270, 2041, 10.1074/jbc.270.5.2041 · DOI · Paper page
- Westphal, 1999, Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex, Science, 285, 93, 10.1126/science.285.5424.93 · DOI · Paper page
- Whitehouse, 1982, Purification of a physiological form of the inhibitor protein of the cAMP-dependent protein kinase, J. Biol. Chem., 257, 6028, 10.1016/S0021-9258(20)65100-6 · doi:10.1016/s0021-9258(20)65100-6
- Whitehouse, 1983, Mg•ATP2−-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit, J. Biol. Chem., 258, 3682, 10.1016/S0021-9258(18)32719-4 · DOI · Paper page
- Wiley, 1999, Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A, J. Biol. Chem., 274, 6381, 10.1074/jbc.274.10.6381 · doi:10.1074/jbc.274.10.6381
- Zheng, 2000, Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA, Biochem. J., 349, 403, 10.1042/0264-6021:3490403 · doi:10.1042/0264-6021:3490403
Cited by
Pharmacological PKA Inhibition: All May Not Be What It Seems
Murray, A. J. (2008) · Science Signaling · doi:10.1126/scisignal.122re4 · Cited by 327
The Many Faces of H89: A Review
Lochner, A., & Moolman, J. A. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00261.x · Cited by 314
Subcellular Organization of the cAMP Signaling Pathway
Zaccolo, M., Zerio, A., & Lobo, M. J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000086 · Cited by 275
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
Mortimer, L., Moreau, F., MacDonald, J. A., & Chadee, K. (2016) · Nature Immunology · doi:10.1038/ni.3538 · Cited by 254
MicroRNA-155 Is Required for Mycobacterium bovis BCG-Mediated Apoptosis of Macrophages
Ghorpade, D. S., Leyland, R., Kurowska-Stolarska, M., Patil, S. A., & Balaji, K. N. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06597-11 · Cited by 142
Metadata
- Authors
- Dalton, G. D., & Dewey, W. L.
- Venue
- Neuropeptides
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 40
- Issue
- 1
- Pages
- 23-34
- ISSN
- 0143-4179
- Cited by
- 135
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein kinase inhibitor peptide (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. https://app.cochat.ai/papers/10.1016/j.npep.2005.10.002
- The paper
- Dalton, G. D., & Dewey, W. L. (2006). Protein kinase inhibitor peptide (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides. https://doi.org/10.1016/j.npep.2005.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.